Elif Bulut1, Emine Pektas2, Hatice S Sivri2, Burcak Bilginer3, Mumtaz M Umaroglu4, Burce Ozgen1. 1. 1 Department of Radiology, Hacettepe University Faculty of Medicine , Ankara , Turkey. 2. 2 Department of Pediatric Metabolism, Hacettepe University Faculty of Medicine , Ankara , Turkey. 3. 3 Department of Neurosurgery, Hacettepe University Faculty of Medicine , Ankara , Turkey. 4. 4 Department of Biostatistics, Hacettepe University , Ankara , Turkey.
Abstract
OBJECTIVE: To evaluate spinal MRI features of mucopolysaccharidosis (MPS) VI and to assess the correlation with clinical findings. METHODS: We retrospectively evaluated spinal MRI scans and clinical findings at the time of imaging in 14 patients (8 male, 6 female) with MPS VI. Craniometric measurements were performed and the images were assessed for bony anomalies, spinal stenosis and spinal cord compression. The degree of cervical cord compression was scored and correlated with neurological examination findings at the time of imaging. Vertebral alignment, structural changes in spinal ligaments and intervertebral discs were also assessed. RESULTS: All patients had cervical stenosis due to bony stenosis and thickened retrodental tissue (median: 6.05 mm, range 3.3-8 mm). Retrodental tissue thickness was found to increase with age (p = 0.042). Compressive myelopathy was detected at upper cervical level in 11 (79%) and lower thoracic level in 2 patients (14%). Significant inverse correlation was found between cervical myelopathy scores and neurological strength scores. The most common bony changes were hypo/dysplastic odontoid; cervical platyspondyly with anterior inferior beaking; thoracic posterior end plate depressions and lumbar posterior scalloping. Kyphosis due to retrolisthesis of the beaked lumbar vertebrae and acute sacrococcygeal angulations were other remarkable findings. CONCLUSION: MRI is an essential component in evaluation of spinal involvement in MPS VI, and scanning of the entire spine is recommended to rule out thoracic cord compression. Advances in knowledge: This study provides a detailed description of spinal MRI findings in MPS VI and underlines the role of MRI in management of cord compression.
OBJECTIVE: To evaluate spinal MRI features of mucopolysaccharidosis (MPS) VI and to assess the correlation with clinical findings. METHODS: We retrospectively evaluated spinal MRI scans and clinical findings at the time of imaging in 14 patients (8 male, 6 female) with MPS VI. Craniometric measurements were performed and the images were assessed for bony anomalies, spinal stenosis and spinal cord compression. The degree of cervical cord compression was scored and correlated with neurological examination findings at the time of imaging. Vertebral alignment, structural changes in spinal ligaments and intervertebral discs were also assessed. RESULTS: All patients had cervical stenosis due to bony stenosis and thickened retrodental tissue (median: 6.05 mm, range 3.3-8 mm). Retrodental tissue thickness was found to increase with age (p = 0.042). Compressive myelopathy was detected at upper cervical level in 11 (79%) and lower thoracic level in 2 patients (14%). Significant inverse correlation was found between cervical myelopathy scores and neurological strength scores. The most common bony changes were hypo/dysplastic odontoid; cervical platyspondyly with anterior inferior beaking; thoracic posterior end plate depressions and lumbar posterior scalloping. Kyphosis due to retrolisthesis of the beaked lumbar vertebrae and acute sacrococcygeal angulations were other remarkable findings. CONCLUSION: MRI is an essential component in evaluation of spinal involvement in MPS VI, and scanning of the entire spine is recommended to rule out thoracic cord compression. Advances in knowledge: This study provides a detailed description of spinal MRI findings in MPS VI and underlines the role of MRI in management of cord compression.
Authors: Dafne Dain Gandelman Horovitz; Tatiana de Sá Pacheco Carneiro Magalhães; Alessandra Pena e Costa; Luis Eduardo Carelli; Daniel Souza e Silva; Anna Patricia Freitas de Linhares e Riello; Juan Clinton Llerena Journal: Mol Genet Metab Date: 2011-07-23 Impact factor: 4.797
Authors: Guirish A Solanki; Tord D Alden; Barbara K Burton; Roberto Giugliani; Dafne D G Horovitz; Simon A Jones; Christina Lampe; Kenneth W Martin; Maura E Ryan; Matthias K Schaefer; Aisha Siddiqui; Klane K White; Paul Harmatz Journal: Mol Genet Metab Date: 2012-07-21 Impact factor: 4.797
Authors: Felippe Borlot; Paula Ricci Arantes; Caio Robledo Quaio; José Francisco da Silva Franco; Charles Marques Lourenço; Debora Romeo Bertola; Chong Ae Kim Journal: Brain Dev Date: 2013-08-21 Impact factor: 1.961
Authors: Karolina M Stepien; Andrew Bentley; Cliff Chen; M Wahab Dhemech; Edward Gee; Peter Orton; Catherine Pringle; Jonathan Rajan; Ankur Saxena; Govind Tol; Chaitanya Gadepalli Journal: Front Cardiovasc Med Date: 2022-03-07
Authors: Roberta Reichert; Juliano A Pérez; Amauri Dalla-Corte; Filippo Pinto E Vairo; Carolina F M de Souza; Roberto Giugliani; Gustavo R Isolan; Marco Antonio Stefani Journal: JIMD Rep Date: 2021-03-21